Sutro Biopharma Statistics Share Statistics Sutro Biopharma has 84.77M
shares outstanding. The number of shares has increased by 2.81%
in one year.
Shares Outstanding 84.77M Shares Change (YoY) 2.81% Shares Change (QoQ) 0.37% Owned by Institutions (%) 65.72% Shares Floating 67.14M Failed to Deliver (FTD) Shares 12,010 FTD / Avg. Volume 2.5%
Short Selling Information The latest short interest is 2.52M, so 2.97% of the outstanding
shares have been sold short.
Short Interest 2.52M Short % of Shares Out 2.97% Short % of Float 2.99% Short Ratio (days to cover) 3.67
Valuation Ratios The PE ratio is -0.62 and the forward
PE ratio is -0.89.
Sutro Biopharma's PEG ratio is
-0.01.
PE Ratio -0.62 Forward PE -0.89 PS Ratio 2.28 Forward PS 1.6 PB Ratio 3.17 P/FCF Ratio -0.73 PEG Ratio -0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Sutro Biopharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.6,
with a Debt / Equity ratio of 0.52.
Current Ratio 2.6 Quick Ratio 2.6 Debt / Equity 0.52 Debt / EBITDA -0.13 Debt / FCF -0.12 Interest Coverage -7.67
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $230.64K Profits Per Employee $-845.58K Employee Count 269 Asset Turnover 0.16 Inventory Turnover n/a
Taxes Income Tax 2.36M Effective Tax Rate -1.05%
Stock Price Statistics The stock price has increased by -74.79% in the
last 52 weeks. The beta is 1.62, so Sutro Biopharma's
price volatility has been higher than the market average.
Beta 1.62 52-Week Price Change -74.79% 50-Day Moving Average 0.88 200-Day Moving Average 1.12 Relative Strength Index (RSI) 52.6 Average Volume (20 Days) 479,965
Income Statement In the last 12 months, Sutro Biopharma had revenue of 62.04M
and earned -227.46M
in profits. Earnings per share was -2.96.
Revenue 62.04M Gross Profit 54.83M Operating Income -238.45M Net Income -227.46M EBITDA -180.45M EBIT -187.67M Earnings Per Share (EPS) -2.96
Full Income Statement Balance Sheet The company has 190.3M in cash and 23.15M in
debt, giving a net cash position of 167.15M.
Cash & Cash Equivalents 190.3M Total Debt 23.15M Net Cash 167.15M Retained Earnings -786.87M Total Assets 262.36M Working Capital 157.38M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -191.54M
and capital expenditures -3.1M, giving a free cash flow of -194.64M.
Operating Cash Flow -191.54M Capital Expenditures -3.1M Free Cash Flow -194.64M FCF Per Share -2.53
Full Cash Flow Statement Margins Gross margin is 88.37%, with operating and profit margins of -384.34% and -366.62%.
Gross Margin 88.37% Operating Margin -384.34% Pretax Margin -362.81% Profit Margin -366.62% EBITDA Margin -290.85% EBIT Margin -384.34% FCF Margin -313.71%
